U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    TYK2 tyrosine kinase 2 [ Homo sapiens (human) ]

    Gene ID: 7297, updated on 4-Jan-2025

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.

    TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.
    Benmansour R, Tagajdid MR, El Hamzaoui H, Fjouji S, Doghmi N, Houba A, Belbacha I, Elkochri S, Aabi R, Elannaz H, Laraqui A, El Mchichi B, Chmitah T, Touil N, Ennibi K, Eljaoudi R, Elmir E, Amine Lahlou I, Oumzil H., Free PMC Article

    08/16/2024
    Associations of genetic variants within TYK2 with pulmonary tuberculosis among Chinese population.

    Associations of genetic variants within TYK2 with pulmonary tuberculosis among Chinese population.
    Zhang M, Liu Z, Zhu Y, Wu K, Zhou L, Peng Y, Pan J, Chen B, Wang X, Chen S., Free PMC Article

    06/25/2024
    Community analysis of large-scale molecular dynamics simulations elucidated dynamics-driven allostery in tyrosine kinase 2.

    Community analysis of large-scale molecular dynamics simulations elucidated dynamics-driven allostery in tyrosine kinase 2.
    Lesgidou N, Vlassi M.

    03/8/2024
    Direct and biologically significant interactions of human herpesvirus 8 interferon regulatory factor 1 with STAT3 and Janus kinase TYK2.

    Direct and biologically significant interactions of human herpesvirus 8 interferon regulatory factor 1 with STAT3 and Janus kinase TYK2.
    Yang Z, Xiang Q, Nicholas J., Free PMC Article

    12/20/2023
    Tick-borne flavivirus NS5 antagonizes interferon signaling by inhibiting the catalytic activity of TYK2.

    Tick-borne flavivirus NS5 antagonizes interferon signaling by inhibiting the catalytic activity of TYK2.
    Gracias S, Chazal M, Decombe A, Unterfinger Y, Sogues A, Pruvost L, Robert V, Lacour SA, Lemasson M, Sourisseau M, Li Z, Richardson J, Pellegrini S, Decroly E, Caval V, Jouvenet N., Free PMC Article

    12/18/2023
    The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia.

    The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia.
    Zhu L, Li X, Liu D, Bai W, Yang H, Cheng Q, Xu L, Fang J.

    07/31/2023
    TYK2 single-nucleotide variants associated with the severity of COVID-19 disease.

    TYK2 single-nucleotide variants associated with the severity of COVID-19 disease.
    Zabihi Rizi F, Ghorbani A, Zahtab P, Darbaghshahi NN, Ataee N, Pourhamzeh P, Hamzei B, Dolatabadi NF, Zamani A, Hooshmand M., Free PMC Article

    03/28/2023
    Tyk2 Targeting in Immune-Mediated Inflammatory Diseases.

    Tyk2 Targeting in Immune-Mediated Inflammatory Diseases.
    Rusiñol L, Puig L., Free PMC Article

    03/1/2023
    Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19.

    Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19.
    Dieter C, de Almeida Brondani L, Lemos NE, Schaeffer AF, Zanotto C, Ramos DT, Girardi E, Pellenz FM, Camargo JL, Moresco KS, da Silva LL, Aubin MR, de Oliveira MS, Rech TH, Canani LH, Gerchman F, Leitão CB, Crispim D., Free PMC Article

    02/11/2023
    Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway.

    Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway.
    Loo WJ, Turchin I, Prajapati VH, Gooderham MJ, Grewal P, Hong CH, Sauder M, Vender RB, Maari C, Papp KA.

    02/4/2023
    The type 1 diabetes gene TYK2 regulates beta-cell development and its responses to interferon-alpha.

    The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α.
    Chandra V, Ibrahim H, Halliez C, Prasad RB, Vecchio F, Dwivedi OP, Kvist J, Balboa D, Saarimäki-Vire J, Montaser H, Barsby T, Lithovius V, Artner I, Gopalakrishnan S, Groop L, Mallone R, Eizirik DL, Otonkoski T., Free PMC Article

    11/5/2022
    Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk.

    Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk.
    Yarmolinsky J, Amos CI, Hung RJ, Moreno V, Burrows K, Smith-Byrne K, Atkins JR, Brennan P, Colon Cancer Family Registry (CCFR), Colorectal Cancer Transdisciplinary Study (CORECT), Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) Consortium, McKay JD, Martin RM, Davey Smith G., Free PMC Article

    10/29/2022
    Impaired IL-23-dependent induction of IFN-gamma underlies mycobacterial disease in patients with inherited TYK2 deficiency.

    Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.
    Ogishi M, Arias AA, Yang R, Han JE, Zhang P, Rinchai D, Halpern J, Mulwa J, Keating N, Chrabieh M, Lainé C, Seeleuthner Y, Ramírez-Alejo N, Nekooie-Marnany N, Guennoun A, Muller-Fleckenstein I, Fleckenstein B, Kilic SS, Minegishi Y, Ehl S, Kaiser-Labusch P, Kendir-Demirkol Y, Rozenberg F, Errami A, Zhang SY, Zhang Q, Bohlen J, Philippot Q, Puel A, Jouanguy E, Pourmoghaddas Z, Bakhtiar S, Willasch AM, Horneff G, Llanora G, Shek LP, Chai LYA, Tay SH, Rahimi HH, Mahdaviani SA, Nepesov S, Bousfiha AA, Erdeniz EH, Karbuz A, Marr N, Navarrete C, Adeli M, Hammarstrom L, Abolhassani H, Parvaneh N, Al Muhsen S, Alosaimi MF, Alsohime F, Nourizadeh M, Moin M, Arnaout R, Alshareef S, El-Baghdadi J, Genel F, Sherkat R, Kiykim A, Yücel E, Keles S, Bustamante J, Abel L, Casanova JL, Boisson-Dupuis S., Free PMC Article

    10/1/2022
    Novel mutations of TYK2 leading to divergent clinical phenotypes.

    Novel mutations of TYK2 leading to divergent clinical phenotypes.
    Lv G, Sun G, Wu P, Du X, Zeng T, Wen W, Zhou L, An Y, Tang X, He T, Zhao X, Du H.

    07/2/2022
    Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

    Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.
    Zhang Q, Matuozzo D, Le Pen J, Lee D, Moens L, Asano T, Bohlen J, Liu Z, Moncada-Velez M, Kendir-Demirkol Y, Jing H, Bizien L, Marchal A, Abolhassani H, Delafontaine S, Bucciol G, COVID Human Genetic Effort, Bayhan GI, Keles S, Kiykim A, Hancerli S, Haerynck F, Florkin B, Hatipoglu N, Ozcelik T, Morelle G, Zatz M, Ng LFP, Lye DC, Young BE, Leo YS, Dalgard CL, Lifton RP, Renia L, Meyts I, Jouanguy E, Hammarström L, Pan-Hammarström Q, Boisson B, Bastard P, Su HC, Boisson-Dupuis S, Abel L, Rice CM, Zhang SY, Cobat A, Casanova JL., Free PMC Article

    06/25/2022
    Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients.

    Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients.
    Akbari M, Akhavan-Bahabadi M, Shafigh N, Taheriazam A, Hussen BM, Sayad A, Fathi M, Taheri M, Ghafouri-Fard S, Fathi M., Free PMC Article

    04/23/2022
    The rs2304256 Polymorphism in TYK2 Gene Is Associated with Protection for Type 1 Diabetes Mellitus.

    The rs2304256 Polymorphism in TYK2 Gene Is Associated with Protection for Type 1 Diabetes Mellitus.
    Pellenz FM, Dieter C, Duarte GCK, Canani LH, de Souza BM, Crispim D., Free PMC Article

    03/12/2022
    Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia.

    Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia.
    Tavakoli Shirazi P, Eadie LN, Page EC, Heatley SL, Bruning JB, White DL.

    11/22/2021
    Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms With Systemic Sclerosis in a Chinese Han Population.

    Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms With Systemic Sclerosis in a Chinese Han Population.
    Liu C, Yan S, Chen H, Wu Z, Li L, Cheng L, Li H, Li Y., Free PMC Article

    09/25/2021
    TYK2 Promoter Variant Is Associated with Impaired Insulin Secretion and Lower Insulin Resistance in Japanese Type 2 Diabetes Patients.

    TYK2 Promoter Variant Is Associated with Impaired Insulin Secretion and Lower Insulin Resistance in Japanese Type 2 Diabetes Patients.
    Mori H, Takahashi H, Mine K, Higashimoto K, Inoue K, Kojima M, Kuroki S, Eguchi T, Ono Y, Inuzuka S, Soejima H, Nagafuchi S, Anzai K., Free PMC Article

    08/7/2021
    TYK2 Variants in B-Acute Lymphoblastic Leukaemia.

    TYK2 Variants in B-Acute Lymphoblastic Leukaemia.
    Turrubiartes-Martínez E, Bodega-Mayor I, Delgado-Wicke P, Molina-Jiménez F, Casique-Aguirre D, González-Andrade M, Rapado I, Camós M, Díaz-de-Heredia C, Barragán E, Ramírez-Orellana M, Aguado B, Figuera Á, Martínez-López J, Fernández-Ruiz E., Free PMC Article

    07/24/2021
    Polymorphisms in IRF5 and TYK2 Genes Are Associated with Rheumatoid Arthritis in a Chinese Han Population.

    Polymorphisms in IRF5 and TYK2 Genes Are Associated with Rheumatoid Arthritis in a Chinese Han Population.
    Peng Y, Chen B, Sheng X, Qian Y., Free PMC Article

    05/29/2021
    JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma.

    JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma.
    Meng L, Ding L, Yu Y, Li W., Free PMC Article

    05/8/2021
    Human ancient DNA analyses reveal the high burden of tuberculosis in Europeans over the last 2,000 years.

    Human ancient DNA analyses reveal the high burden of tuberculosis in Europeans over the last 2,000 years.
    Kerner G, Laval G, Patin E, Boisson-Dupuis S, Abel L, Casanova JL, Quintana-Murci L., Free PMC Article

    03/27/2021
    A New Patient with Inherited TYK2 Deficiency.

    A New Patient with Inherited TYK2 Deficiency.
    Sarrafzadeh SA, Mahloojirad M, Casanova JL, Badalzadeh M, Bustamante J, Boisson-Dupuis S, Pourpak Z, Nourizadeh M, Moin M., Free PMC Article

    02/13/2021
    firstprevious page of 5 nextlast